Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 314

1.

Positron Emission Tomography: applications in drug discovery and drug development.

Wang J, Maurer L.

Curr Top Med Chem. 2005;5(11):1053-75. Review.

PMID:
16181131
3.

Small animal PET imaging.

Hutchins GD, Miller MA, Soon VC, Receveur T.

ILAR J. 2008;49(1):54-65.

4.

Fundamentals of positron emission tomography and applications in preclinical drug development.

Cherry SR.

J Clin Pharmacol. 2001 May;41(5):482-91. Review.

PMID:
11361044
5.

Small animal PET in preclinical studies: opportunities and challenges.

Riemann B, Schäfers KP, Schober O, Schäfers M.

Q J Nucl Med Mol Imaging. 2008 Sep;52(3):215-21. Review.

6.

Application of cardiac molecular imaging using positron emission tomography in evaluation of drug and therapeutics for cardiovascular disorders.

Yoshinaga K, Chow BJ, dekemp RA, Thorn S, Ruddy TD, Davies RA, DaSilva JN, Beanlands R.

Curr Pharm Des. 2005;11(7):903-32. Review.

PMID:
15777243
7.

The use of imaging in preclinical drug development.

Vanderheyden JL.

Q J Nucl Med Mol Imaging. 2009 Aug;53(4):374-81.

8.

Radiopharmaceuticals: molecular imaging using positron emission tomography.

Antoni G, Långström B.

Handb Exp Pharmacol. 2008;(185 Pt 1):177-201. doi: 10.1007/978-3-540-72718-7_9. Review.

PMID:
18626804
9.

[Positron emission tomography: a clinical and biological research tool].

Kotzki PO.

J Soc Biol. 2004;198(2):163-8. Review. French.

PMID:
15368968
10.

Positron emission tomography for modeling pathophysiological processes in vivo.

Hendrikse NH, Luurtsema G, van der Veldt AA, Lubberink M.

Curr Opin Drug Discov Devel. 2008 Sep;11(5):717-25. Review.

PMID:
18729023
11.
12.

Small-animal positron emission tomography as a tool for neuropharmacology.

Lancelot S, Zimmer L.

Trends Pharmacol Sci. 2010 Sep;31(9):411-7. doi: 10.1016/j.tips.2010.06.002. Epub 2010 Jul 6. Review.

PMID:
20599282
13.

Target-specific delivery of peptide-based probes for PET imaging.

Chen K, Conti PS.

Adv Drug Deliv Rev. 2010 Aug 30;62(11):1005-22. doi: 10.1016/j.addr.2010.09.004. Epub 2010 Sep 17. Review.

PMID:
20851156
14.

Iodine-124: a promising positron emitter for organic PET chemistry.

Koehler L, Gagnon K, McQuarrie S, Wuest F.

Molecules. 2010 Apr 13;15(4):2686-718. doi: 10.3390/molecules15042686. Review.

15.

Microwave accelerated labeling methods in the synthesis of radioligands for positron emission tomography imaging.

Kallmerten AE, Alexander A, Wager KM, Jones GB.

Curr Radiopharm. 2011 Oct;4(4):343-54. Review.

PMID:
22202157
16.

Immuno-PET: a navigator in monoclonal antibody development and applications.

van Dongen GA, Visser GW, Lub-de Hooge MN, de Vries EG, Perk LR.

Oncologist. 2007 Dec;12(12):1379-89. doi: 10.1634/theoncologist.12-12-1379. Review.

17.

Positron Emission Tomography (PET) and breast cancer in clinical practice.

Lavayssière R, Cabée AE, Filmont JE.

Eur J Radiol. 2009 Jan;69(1):50-8. doi: 10.1016/j.ejrad.2008.07.039. Epub 2008 Sep 23. Review.

PMID:
18814983
18.

Clinical molecular imaging with positron emission tomography.

Saleem A, Charnley N, Price P.

Eur J Cancer. 2006 Aug;42(12):1720-7. Epub 2006 Jun 22. Review.

PMID:
16797972
19.

The future of radioimmunotherapy: a PET perspective.

Conti PS.

Semin Oncol. 2005 Feb;32(1 Suppl 1):S63-7.

PMID:
15786028
20.

Small-animal PET: a promising, non-invasive tool in pre-clinical research.

Schnöckel U, Hermann S, Stegger L, Law M, Kuhlmann M, Schober O, Schäfers K, Schäfers M.

Eur J Pharm Biopharm. 2010 Jan;74(1):50-4. doi: 10.1016/j.ejpb.2009.05.012. Epub 2009 May 29.

PMID:
19482080
Items per page

Supplemental Content

Write to the Help Desk